|
Published by: Venture Planning Group
Published: Sep. 1, 2009 - 420 Pages
Table of Contents
- A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
- 1. Blood Typing and Grouping Tests
- a. ABO
- b. Antibody Panels
- c. Antibody Screening
- d. Antigen Typing
- e. Antiglobulin Test
- f. Crossmatch
- g. HLA Typing
- h. Rh
- i. Other Blood Groups
- 2. Infectious Disease Screening Tests
- a. AIDS
- - Structure and Composition
- - Classification
- - HIV-2 Infection
- - Origin of AIDS
- - Animal Lentivirus Systems
- - Virus Receptors
- - HIV Infections in Humans
- -Pathogenesis & Pathology
- -Overview of Course of HIV Infection
- - CD4T Lymphocytes and Memory Cells
- - Monocytes and Macrophages
- - Lymphoid Organs
- - Neural Cells
- - Viral Coinfections
- -Clinical Findings
- - Plasma Viral Load
- - Pediactric AIDS
- -Neurologic Disease
- -Opportunistic Infections
- -Protozoa
- -Fungi
- -Bacteria
- -Viruses
- -Cancer
- - Immunity
- - Laboratory Diagnosis
- -Virus Isolation
- -Serology
- -Detection of Viral Nucleic Acid or Antigens
- - Epidemiology
- -Worldwide Spread of AIDS
- -United States
- -Routes of Transmission
- - Prevention, Treatment, And Control
- -Antiviral Drugs
- -Vaccines Against HIV
- - Transmission of HIV in Blood Products
- - HIV Transmission in Transplant and Artificial Insemination Recipients
- - Diagnostic Tests
- -Enzyme Immunoassay Interpretation
- -Specificity, Sensitivity, and Predictive
- Value of Enzyme Immunoassay
- - Competition Assays
- - Western Blot Technique
- - Immuno-Fluorescence Assay (IFA)
- - Radioimmunoprecipitation
- - HIV-1/HIV-2 Combination Testing
- - Methods of HIV-Antigen Detection
- - Antigen Assays and Blood Screening
- - Urine Tests
- - DNA Probes
- - Overview
- - Quantitative Polymerase Chain Reaction
- - In Situ PCR
- - Needed Improvements
- - Viral Load/Drug Resistance Testing
- - Genotype and Phenotype Testing
- - Blood Banking Considerations
- b. Hepatitis
- - Hepatitis A
- - Hepatitis B
- -Structure and Composition
- -Replication of Hepatitis B Virus
- - Hepatitis C
- - Hepatitis D (Delta Hepatitis)
- - Hepatitis E
- - Hepatitis G
- - Hepatitis Virus Infections In Humans
- -Pathology
- - Clinical Findings
- - Laboratory Features
- -Hepatitis A
- -Hepatitis B
- -Hepatitis C
- -Hepatitis D
- -Hepatitis E
- - Virus-Host Immune Reactions
- - Epidemiology
- -Hepatitis A
- -Hepatitis B
- -Hepatitis C
- -Hepatitis D (Delta Agent)
- - Vaccines and Drugs
- c. Cytomegalovirus
- - Background
- - Chorioretinitis
- - Gastrointestinal
- - Central Nervous System Disease
- - Diagnostic Tests
- - Vaccines and Drugs
- d. Syphilis
- - Background
- - Diagnostic Tests
- - Vaccines and Drugs
- e. West Nile Virus
- - Background
- - Clinical Syndromes
- - Diagnostic Tests
- - Vaccines and Drugs
- f. Parvovirus B19
- - Microbiology
- - Epidemiology
- - Clinical Syndromes
- -Erythema Infectiosum Slapped (cheek)
- -Adult Polyarthropathy
- -Transient Aplastic Crisis
- -Transient Pancytopenia
- -Red Cell Aplasia in the Immunocompromised
- -Perinatal Infections
- - Diagnosis
- - Treatment
- g. Creutzfeldt-Jakob’s Disease
- - Background
- - Transmission
- - Diagnostic Tests
- - Major Commercial and Academic Players
- -Bayer
- -Disease Sciences/BioTec Global
- -Imperial College School of Medicine
- -Ortho-Clinical Diagnostics
- -Pall
- -ProMetic Life Sciences
- -Proteome Sciences/Idexx
- -Q-One Biotech
- -Serono
- -U.S. Agricultural Research Service
- - Drugs
- - Vaccines
- h. Malaria
- i. Chagas Disease
- j. Babesiosis
- 3. Pathogen Reduction
- 4. Leukocyte Reduction
- - Background
- - Methods
- B. Instrumentation Review
- Introduction
- 1. Abbott Prism
- 2. Abbott Quantum II
- 3. Abbott Commander
- 4. BioMeriuex BacT/Alert
- 5. Dade Behring Quadriga
- 6. Dade Behring BEP 2000
- 7. Grifols Diana
- 8. Immucor ABS2000
- 9. Immucor Galile
- 10. Immucor Rosys Plato
- 11. Olympus PK7100
- 12. Olympus PK7200
- 13. Olympus PK80
- 14. Olympus BloodTrack Courier
- 15. Ortho AutoVue/ProVue
- 16. Ortho Summit Processor
- 17. Tecan ELPHAtyper
- 18. Tecan Hemotyper
- 19. Tecan MegaFlex
- 20. Tecan MiniSwift
- C. Major in Vitro Diagnostic Technologies And Their Potential Applications
- 1. Molecular Diagnostics
- a. Overview
- b. NAT
- 2. Monoclonal and Polyclonal Antibodies
- 3. Immunoassays
- a. Technological Principle
- b. Enzyme Immunoassays (EIA)
- - Overview
- - ELISA
- - Enzyme Amplification
- c. Fluorescent Immunoassays
- - Fluorescence Polarization
- d. Luminescence
- - Chemiluminescence
- - Bioluminescence
- e. Latex Agglutination
- f. Immunoprecipitation
- 4. Microtitration Plates
- 5. Microcomputers
- 6. Automation
- 7. Lasers
- 8. Robotics
- 9. Artificial Intelligence
- 10. Synthetic Red Cell Substitutes
- 11. Genetically Engineered Blood Components
- a. Albumin
- b. Factor VIII
- c. Alpha-2 Antiplasmin
- d. Antithrombin III
- e. Factor IX
- f. Von Willebrand's Factor
- g. Fibrinogen
- h. t-PA
- 12. Blood Preservation
- 13. Autologous Blood Transfusion/Freezing
- D. Worldwide Market Overview
- 1. Business Environment
- 2. Market Structure
- 3. Market Size and Growth
- Germany
- A. Executive Summary
- B. Business Environment
- C. Market Structure
- D. Market Size, Growth and Major Suppliers’
- Consumable Sales, Instrument Placements,
- Installed Base and Market Shares
- Major Product Development Opportunities
- A. Blood Typing and Grouping
- B. Infectious Disease Screening
- C. Auxiliary
- Alternative Market Penetration Strategies
- A. Internal Development
- B. Collaborative Arrangements
- C. University Contracts
- Potential Market Entry Barriers and Risks
- A. Market Maturity
- B. Cost Containment
- C. Competition
- D. Technological Edge and Limitations
- E. Patent Protection
- F. Regulatory Constraints
- Competitive Assessments
- - Abbott
- - Beckman Coulter
- - Biokit
- - BioMerieux
- - Bio-Rad
- - Bioscot
- - Biotest
- - Chiron
- - Diagast
- - Diamed
- - DiaSorin
- - Fujirebio
- - Gen-Probe
- - Gradipore
- - Grifols
- - ImmucorGamma
- - Innogenetics
- - Orchid Biosciences
- - Ortho-Clinical Diagnostics
- - Proteome Sciences
- - Roche
- - Siemens
- - Tecan
- Appendix: Assumed Currency Exchange Rates
- List of Tables
- Major Companies Developing or Marketing Blood Typing and Grouping Tests
- Major Companies Developing or Marketing HLA Typing Tests
- Major Companies Developing or Marketing AIDS Tests
- Major Companies Developing or Marketing Hepatitis Tests
- Major Companies Developing or Marketing CMV Tests
- Major Companies Developing or Marketing Syphilis Tests
- Major Companies Developing or Marketing Blood Bank Analyzers
- Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country
- Worldwide, All Market Segments, Total Blood Typing and Grouping Test Volume Forecast By Country
- Worldwide, All Market Segments, Total Infectious Disease Screening Test Volume Forecast
- Worldwide, All Market Segments, Total Blood Typing and Grouping Reagent Market Forecast By Country
- Worldwide, All Market Segments, Total Infectious Disease Reagent Market Forecast By Country
- Executive Summary Table: Germany, Total Blood Bank Test Volume and Reagent Sales Forecast By Test Category
- Germany, Facilities Performing Blood Bank Tests By Market Segment
- Germany, Hospital Laboratories Performing Blood Bank Tests By Bed Size
- Germany, Commercial/Private Laboratories Performing Blood Bank Tests By Annual Test Volume
- Germany, All Market Segments Blood Typing and Grouping Test Volume Forecast By Market Segment
- Germany, All Market Segments Blood Typing and Grouping Test Volume Forecast
- Germany, Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
- Germany, Blood Banks Blood Typing and Grouping Test Volume Forecast
- Germany, Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
- Germany, All Market Segments Infectious Disease Screening Test Volume Forecast By Market Segment
- Germany, All Market Segments Infectious Disease Screening Test Volume Forecast
- Germany, Blood Banks Infectious Disease Screening Test Volume Forecast
- Germany, Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
- Germany, Hospital Laboratories Infectious Disease Screening Test Volume Forecast
- Germany, All Market Segments Blood Typing and Grouping Reagent Market Forecast By Market Segment
- Germany, All Market Segments Blood Typing and Grouping Reagent Market Forecast By Major Test
- Germany, Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
- Germany, Blood Banks Blood Typing and Grouping Reagent Market By Major Test Forecast
- Germany, Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
- Germany, All Market Segments Infectious Disease Screening Reagent Market Forecast By Market Segment
- Germany, All Market Segments Infectious Disease Screening Reagent Market Forecast By Test
- Germany, Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
- Germany, Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast By Test
- Germany, Hospital Laboratories Infectious Disease Screening Reagent Market Forecast By Test
- Germany, Major Suppliers of Blood Typing and Grouping Reagents Estimated Sales and Market Shares
- Germany, HIV-1/2 Blood Screening Market, Reagent Sales By Major Supplier
- Germany, Hepatitis Blood Screening Market, Reagent Sales By Major Supplier
- Germany, HIV/Hepatitis NAT Market, Reagent Sales by Major Supplier
- Germany, CMV Blood Screening Market, Reagent Sales By Major Supplier
- Germany, Syphilis Blood Screening Market, Reagent Sales By Major Supplier
- Germany, Major Suppliers of Blood Bank Automated Analyzers, Estimated Placements and Installed Base By Supplier and Model
AbstractThis report presents a comprehensive analysis of the German blood banking market, including:- Major issues pertaining to the German blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in German blood banks, hospitals and commercial laboratories.
- Annual placements and installed base estimates for major automated and semiautomated analyzers.
- Review of current instrumentation technologies, and a feature comparison of over 20 analyzers.
- Ten-year reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of current and emerging technologies, and their potential market applications
- Product development opportunities for instruments, consumables, and auxiliary products.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
- Business opportunities and strategic recommendations for suppliers.
Contains 420 pages and 43 tables
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
